BioSec and Fujitsu demonstrating biometric stadium security solution at Arena Summit

Hungarian security company BioSec and its technology partner Fujitsu will demonstrate an interactive stadium security concept based on biometric palm vein recognition at the Arena Summit this week in Germany.

BioSec’s StadiumGuard stadium security and service solution package is currently deployed at Hungarian Groupama Arena to prevent football spectator violence. StadiumGuard is a palm vein scanner solution that grants access to thousands of ticket holders into the stadium, while keeping banned individuals outside. The technology works by fans waving their hand above the sensor at one of the stadium’s 36 gates. If the person is not blacklisted, the sensor will immediately activate a green light.

“Violence-free sports events and family-friendly stadiums are not magic,” explains BioSec Group CEO, Péter Györgydeák. “It is ‘just’ technology.”

BioSec and Fujitsu will also deliver a presentation on the benefits of palm vein recognition-based authentication at sports events at the show.

In August BioSec revealed that it has developed a rapid deployment biometric authentication solution for securing large events. BS RapidGuard uses palm vein recognition to ensure 100% personalized tickets for high security authentication and access control.

Article Topics

access control  |  biometrics  |  Biosec  |  Fujitsu  |  palm vein authentication